Share
CHENNAI: Indian Institute of Technology Madras’ Team Avishkar Hyperloop has made rapid strides since it became the debut finalist and the only Asian team to qualify for the finals of SpaceX Hyperloop Pod Competition 2019, a global contest organized by SpaceX, the American aerospace manufacturer. It was one of the Top 21 teams out of more than 1,600 teams participating globally in this event.
Despite the challenges from the pandemic and the lockdowns, the 40 students of Team Avishkar collaborated on this Hyperloop pod development from their homes to completely revamp the pods’ sub-systems with scalable and efficient technologies. In the past few months, they have manufactured a Hyperloop Pod Prototype and tested the novel technology.
IIT Madras student team qualifies for European Hyperloop Week
prokerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prokerala.com Daily Mail and Mail on Sunday newspapers.
IIT Madras to launch Shaastra, an online tech magazine
thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.
Researchers to study Indomethacin’s impact on oxygen need in Covid patients
April 28, 2021
×
After seeing encouraging results in a pilot study done last year, Indian researchers are now planning to conduct a randomised control trial (RCT) to understand the efficacy and safety of indomethacin in providing faster symptomatic relief and reduction in oxygen requirement in Covid-19 patients.
Indomethacin is a nonsteroidal, anti-inflammatory drug (NSAID) commonly used to reduce fever, pain, stiffness, and swelling caused by rheumatoid arthritis.
In December 2020, Medrxiv published a preprint of a study conducted by a group of doctors, who advanced the case use of Indomethacin for faster symptomatic relief and preventing progression of pneumonia in Covid-19 patients.